Department of Chemistry and Biochemistry, University of California, San Diego, 9500 Gilman Drive, La Jolla, California 92093, United States.
Acc Chem Res. 2024 May 7;57(9):1325-1335. doi: 10.1021/acs.accounts.4c00042. Epub 2024 Apr 13.
In 1960, Weber prophesied that "There are many ways in which the properties of the excited state can be utilized to study points of ignorance of the structure and function of proteins". This has been realized, illustrating that an intrinsic and highly responsive fluorophore such as tryptophan can alter the course of an entire scientific discipline. But what about RNA and DNA? Adapting Weber's protein photophysics prophecy to nucleic acids requires the development of intrinsically emissive nucleoside surrogates as, unlike Trp, the canonical nucleobases display unusually low emission quantum yields, which render nucleosides, nucleotides, and oligonucleotides practically dark for most fluorescence-based applications.Over the past decades, we have developed emissive nucleoside surrogates that facilitate the monitoring of nucleoside-, nucleotide-, and nucleic acid-based transformations at a nucleobase resolution in real time. The premise underlying our approach is the identification of minimal atomic/structural perturbations that endow the synthetic analogs with favorable photophysical features while maintaining native conformations and pairing. As illuminating probes, the photophysical parameters of such isomorphic nucleosides display sensitivity to microenvironmental factors. Responsive isomorphic analogs that function similarly to their native counterparts in biochemical contexts are defined as isofunctional.Early analogs included pyrimidines substituted with five-membered aromatic heterocycles at their 5 position and have been used to assess the polarity of the major groove in duplexes. Polarized quinazolines have proven useful in assembling FRET pairs with established fluorophores and have been used to study RNA-protein and RNA-small-molecule binding. Completing a fluorescent ribonucleoside alphabet, composed of visibly emissive purine (A, G) and pyrimidine (U, C) analogs, all derived from thieno[3,4-]pyrimidine as the heterocyclic nucleus, was a major breakthrough. To further augment functionality, a second-generation emissive RNA alphabet based on an isothiazolo[4,3-]pyrimidine core (A, G, U, and C) was fabricated. This single-atom "mutagenesis" restored the basic/coordinating nitrogen corresponding to N7 in the purine skeleton and elevated biological recognition.The isomorphic emissive nucleosides and nucleotides, particularly the purine analogs, serve as substrates for diverse enzymes. Beyond polymerases, we have challenged the emissive analogs with metabolic and catabolic enzymes, opening optical windows into the biochemistry of nucleosides and nucleotides as metabolites as well as coenzymes and second messengers. Real-time fluorescence-based assays for adenosine deaminase, guanine deaminase, and cytidine deaminase have been fabricated and used for inhibitor discovery. Emissive cofactors (e.g., SAM), coenzymes (e.g., NAD), and second messengers (e.g., c-di-GMP) have been enzymatically synthesized, using NTPs and native enzymes. Both their biosynthesis and their transformations can be fluorescently monitored in real time.Highly isomorphic and isofunctional emissive surrogates can therefore be fabricated and judiciously implemented. Beyond their utility, side-by-side comparison to established analogs, particularly to 2-aminopurine, the workhorse of nucleic acid biophysics over 5 decades, has proven prudent as they refined the scope and limitations of both the new analogs and their predecessors. Challenges, however, remain. Associated with such small heterocycles are relatively short emission wavelengths and limited brightness. Recent advances in multiphoton spectroscopy and further structural modifications have shown promise for overcoming such barriers.
1960 年,Weber 曾预言“可以利用激发态的许多性质来研究蛋白质结构和功能未知的方面”。这一预言已经被证实,阐明了色氨酸等内在且高度响应的荧光团可以改变整个科学学科的进程。那么 RNA 和 DNA 呢?将 Weber 关于蛋白质光物理的预言应用于核酸需要开发内在发光的核苷类似物,因为与色氨酸不同,典型的核碱基显示出异常低的发射量子产率,这使得核苷、核苷酸和寡核苷酸在大多数基于荧光的应用中实际上是暗的。在过去的几十年中,我们已经开发出了发光的核苷类似物,可实时以核碱基分辨率监测核苷、核苷酸和基于核酸的转化。我们方法的前提是确定最小的原子/结构扰动,这些扰动赋予合成类似物有利的光物理特性,同时保持其天然构象和配对。作为发光探针,这种同构核苷的光物理参数对微环境因素敏感。在生化环境中与天然类似物功能相似的响应性同构类似物被定义为同功。早期的类似物包括在其 5 位取代的 5 元芳香杂环的嘧啶,并已被用于评估双链体中主沟的极性。极化的喹唑啉已被证明在与已建立的荧光团组装 FRET 对方面很有用,并已被用于研究 RNA-蛋白质和 RNA-小分子结合。完成由可见发光的嘌呤(A、G)和嘧啶(U、C)类似物组成的荧光核糖核苷字母表,全部由噻吩[3,4-]嘧啶作为杂环核衍生而来,这是一个重大突破。为了进一步增强功能,基于异噻唑并[4,3-]嘧啶核心(A、G、U 和 C)制造了第二代发光 RNA 字母表。这种单原子“诱变”恢复了嘌呤骨架中 N7 对应的基本/配位氮,并提高了生物识别能力。同构发光核苷类似物和核苷酸,特别是嘌呤类似物,可用作多种酶的底物。除了聚合酶之外,我们还通过代谢和分解代谢酶对发光类似物进行了挑战,为核苷和核苷酸作为代谢物以及辅酶和第二信使的生物化学开辟了光学窗口。已经制造了用于腺苷脱氨酶、鸟嘌呤脱氨酶和胞苷脱氨酶的实时荧光测定法,并用于抑制剂的发现。使用 NTP 和天然酶,已经酶促合成了发光辅因子(例如,SAM)、辅酶(例如,NAD)和第二信使(例如,c-di-GMP)。可以实时荧光监测它们的生物合成及其转化。因此,可以制造高度同构和同功的发光类似物,并明智地加以实施。除了它们的用途之外,与已建立的类似物,特别是与在 5 个多世纪以来一直是核酸生物物理学主力的 2-氨基嘌呤进行并排比较,已经被证明是明智的,因为它们改进了新类似物及其前身的范围和局限性。然而,挑战仍然存在。与这种小杂环相关的是相对较短的发射波长和有限的亮度。多光子光谱学和进一步结构修饰的最新进展显示出克服这些障碍的希望。